Get a weekly summary of what Congress did, delivered every Sunday.

  • About
  • How Congress Works
  • Quiz
  • Congress Wrapped
  • Support Us
  • Roadmap
  • Health
  • Privacy Policy
  • Terms of Service
WhiteHouse.wiki•SCOTUS.wiki
Congress.wiki Alpha

This is not an official government website.

© 2026 PLEJ LC. All rights reserved.

Map
Live
Schedule
Daily Record
Special Rules
Subpoenas
House Ethics
Foreign Influence
Agencies
Regulations
Office Spending
US Code
Open search

Federal Regulations

How Congress's laws become real-world rules. Browse regulatory dockets from Regulations.gov — tracking rulemaking activity, public comment periods, and the agencies turning legislation into policy.

Dockets
7,184
Regulations.gov

Showing 30 of 7,184 dockets

Nonrulemaking
FDA
Open for Comments

FDA-2026-P-3102

Requests that the FDA require Postmarket Surveillance, Mandate IDE and PMA Applications, Investigate Potential Misbranding, and Order a Labeling Change to Restrict enVast (K253407) to Guideline-Directed Selective/Bailout Use Only in STEMI with Persistent Large Thrombus Burden

2 docsNo comments
Nonrulemaking
NRCS

NRCS-2025-0203

Information Collection Request: Urban Agriculture and Innovative Production (UAIP) Grants

1 doc5 comments
Nonrulemaking
FDA
Open for Comments

FDA-2026-P-3104

Requests that the FDA makes the determination that CABAZITAXEL injection for intravenous use 60 mg/6 mL (10 mg/mL) [NDA 207970] held by Actavis, LLC, an indirect, wholly-owned subsidiary of Teva Pharmaceuticals USA, Inc. was not discontinued for reasons of safety or effectiveness.

2 docsNo comments
Nonrulemaking
DOT
Open for Comments

DOT-OST-2020-0035

Waiver of the Dormancy and Startup Conditions on Limited Entry Route Authority

113 docs20 comments
Nonrulemaking
DOT
Open for Comments

DOT-OST-2001-8605

Aviones de Oriente, Avior, C.A. - Exemption - Venezuela-United States

25 docsNo comments
Comments due Jan 31, 2007
Nonrulemaking
DOT
Open for Comments

DOT-OST-2006-25984

Avior Airlines, C.A. - Exemption - U.S.-Venezuela

8 docsNo comments
Comments due Dec 7, 2006
Nonrulemaking
DOT
Open for Comments

DOT-OST-2016-0170

Avior Airlines C.A. - Amended Exemption - Caracas, Venezuela-Miami, Florida

9 docsNo comments
Nonrulemaking
EPA

EPA-HQ-OPP-2025-2863

Pesticides: Draft Guidance for Pesticide Registrants on Notifications, Non-Notifications, and Minor Formulation Amendments

4 docs34 comments
Nonrulemaking
FDA

FDA-2025-E-6103

Patent Term Extension Application for WAYRILZ (rilzabrutinib), Patent No. 9,994,576

4 docsNo comments
Nonrulemaking
FDA

FDA-2025-E-6102

Patent Term Extension Application for WAYRILZ (rilzabrutinib), Patent No. 9,266,895

4 docsNo comments
Nonrulemaking
FDA

FDA-2025-E-6101

Patent Term Extension Application for WAYRILZ (rilzabrutinib), Patent No. 8,940,744

4 docsNo comments
Nonrulemaking
FDA

FDA-2025-E-6200

Patent Term Extension Application for VIVJOA (oteseconazole), Patent No. 8,236,962

4 docsNo comments
Nonrulemaking
FDA

FDA-2025-E-6201

Patent Term Extension Application for RHAPSIDO (remibrutinib), Patent No. 9,512,084

4 docsNo comments
Nonrulemaking
FDA

FDA-2024-E-3870

Patent Term Extension Application for Paradise Ultrasound Renal Denervation System, Patent No. 10,456,605

5 docsNo comments
Nonrulemaking
DEA

DEA-2026-0100

Siegfried USA, LLC (DEA 1633)

1 docNo comments
Nonrulemaking
FDA

FDA-2024-E-3869

Patent Term Extension Application Paradise Ultrasound Renal Denervation System, Patent No. 10,350,440

4 docsNo comments
Nonrulemaking
FDA

FDA-2024-E-3868

Patent Term Extension Application for Paradise Ultrasound Renal Denervation System, Patent No. 10,039,901

4 docsNo comments
Nonrulemaking
FDA

FDA-2024-E-3867

Patent Term Extension Application for Paradise Ultrasound Renal Denervation System, Patent No. 9,981,108

4 docsNo comments
Nonrulemaking
FDA

FDA-2024-E-3866

Patent Term Extension Application for Paradise Ultrasound Renal Denervation System, Patent No. 9,943,666

4 docsNo comments
Nonrulemaking
FDA

FDA-2024-E-5945

Patent Term Extension Application for NEXVIAZYME® (avalglucosidase alfa-ngpt), Patent No. 8,759,501

4 docsNo comments
Nonrulemaking
FDA

FDA-2025-E-0160

Patent Term Application for ITOVEBI (inavolisib). Patent No. 10,851,091

4 docsNo comments
Nonrulemaking
FDA

FDA-2025-E-0159

Patent Term Application for ITOVEBI (inavolisib), Patent No. 9,650,393

4 docsNo comments
Nonrulemaking
FDA

FDA-2024-E-4133

Patent Term Extension Application for GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis, Patent No. 9,107,770

5 docsNo comments
Nonrulemaking
FDA

FDA-2025-E-0368

Patent Term Application for FLYRCADO™ (flurpiridaz F 18), Patent No. 9,687,571

4 docsNo comments
Nonrulemaking
FDA

FDA-2025-E-0367

Patent Term Application for FLYRCADO™ (flurpiridaz F 18), Patent No. 9,603,951

4 docsNo comments
Nonrulemaking
FDA

FDA-2025-E-0366

Patent Term Application for FLYRCADO™ (flurpiridaz F 18), Patent No. 9,161,997

4 docsNo comments
Nonrulemaking
FDA

FDA-2026-H-1441

DAB Civil Money Penalty; Valor Vapes LLC d/b/a Smoke Art; CLOSED 3/25/2026

1 docNo comments
Nonrulemaking
FDA

FDA-2025-E-0365

Patent Term Application for FLYRCADO™ (flurpiridaz F 18), Patent No. 8,936,777

4 docsNo comments
Nonrulemaking
FDA

FDA-2025-E-0364

Patent Term Application for FLYRCADO™ (flurpiridaz F 18), Patent No. 8,226,929

4 docsNo comments
Nonrulemaking
FDA

FDA-2025-E-0363

Patent Term Application for FLYRCADO (flurpiridaz F 18), Patent No. 7,344,702

4 docsNo comments
  • Previous
  • Page 136 of 240
  • Next